dc.contributor.author
Ehret, Felix
dc.contributor.author
Hansch, Alexander
dc.contributor.author
Meinhardt, Jenny
dc.contributor.author
Hain, Elisabeth Gertrud
dc.contributor.author
Misch, Martin
dc.contributor.author
Onken, Julia
dc.contributor.author
Roohani, Siyer
dc.contributor.author
Koch, Arend
dc.contributor.author
Schweizer, Leonille
dc.contributor.author
Radke, Josefine
dc.contributor.author
Kaul, David
dc.date.accessioned
2025-03-28T15:47:47Z
dc.date.available
2025-03-28T15:47:47Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/47081
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-46798
dc.rights.uri
https://creativecommons.org/licenses/by-nc/4.0/
dc.subject
DNA methylation
en
dc.subject
dual genotype
en
dc.subject
isocitrate dehydrogenase
en
dc.subject
molecular pathology
en
dc.subject
oligodendroglioma
en
dc.subject
secondary gliomagenesis
en
dc.subject
temozolomide
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Loss of IDH mutation or secondary tumour manifestation? Evolution of an IDH-mutant and 1p/19q-codeleted oligodendroglioma after 15 years of continuous temozolomide treatment and radiotherapy: A case report
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
e12859
dcterms.bibliographicCitation.doi
10.1111/nan.12859
dcterms.bibliographicCitation.journaltitle
Neuropathology and Applied Neurobiology
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.volume
49
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
36332636
dcterms.isPartOf.issn
0305-1846
dcterms.isPartOf.eissn
1365-2990
